| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7946ec4f3ab0ccdf6d369bf5079567ea |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2004-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2837754a5c2f093600c636fefbcc24f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9b7240574d84ce7b6187638ebe2d039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35e02edb91718b7a70f828f73aca8de1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2d9b603d66778b023b538229d8e8c7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c69891c2c6f7c7a91c34ae957793519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bfbd03e0497eb30202192fb73f81084 |
| publicationDate |
2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2341252-T3 |
| titleOfInvention |
COMPOSITIONS THAT INCLUDE POLYPEPTIDES. |
| abstract |
A composition comprising a polypeptide comprising at least two antigen binding sites, wherein said at least two antigen binding sites are located in a single polypeptide chain, and wherein - one of said at least two sites of antigen binding specifically binds to human CD3 antigen; - said polypeptide can exist both in monomeric form and in multimeric form, said monomeric form being said simple polypeptide chain and said multimeric form comprising at least two of said simple polypeptide chains associated not covalently with each other; and - said multimeric form of said polypeptide constitutes no more than 5% of the total weight of the combined monomeric and multimeric forms of said polypeptide. |
| priorityDate |
2003-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |